Morphological and Functional Evaluation of Irvine-Gass Syndrome

Completed

• Conditions: Irvine Gass Syndrome
• Interventions: Behavioral: if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection

• Registration Number: NCT01504074
• Lead Sponsor: Medical University of Vienna

Brief Summary

Purpose: To evaluate morphological and functional characteristics of Irvine Gass syndrome

Methods: 30 patients suffering on Cystoid macular edema (CME) secondary to Cataract surgery will be observed and evaluated by fluorescein-angiography, SD-OCT, reading performance, contrast sensitivity and microperimetry in a fixed time schedule

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-11
• Study First Submitted: 2011-12-28
• Study First Submitted QC: 2012-01-04
• Study First Posted: 2012-01-05
• Primary Completion: 2014-07
• Status Verified: 2015-09
• Last Update Submitted: 2015-09-23
• Last Update Posted: 2015-09-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• > 18 years
• St.p Cataract surgery
• able to read
• informed consent
• with fluorescein angiography and SD-OCT diagnosed Irvine Gass syndrome

Read More

Exclusion Criteria

• < 18 years
• CME of other origin
• diabetic macular edema

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients suffering on CME secondary to cataract surgery	if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection	-

Primary Outcome Measures

Name	Time	Method
Reduction of central retinal thickness	3 months

Secondary Outcome Measures

Name	Time	Method
Increase of Best corrected visual acuity	3 months

Trial Locations

Locations (1)

Department of Ophthalmology Medical University of Vienna; 🇦🇹 Vienna, Austria